New Study Reveals Promising Tumor-Targeting Approach in Pancreatic Cancer Read More » February 10, 2026
Pancreatic cancer trials fuels hope for new drug fast-tracked by the FDA Read More » November 6, 2025
Atebimetinib Plus Chemo Makes Case As Potential Frontline Option in Pancreatic Cancer Read More » October 16, 2025
Neoadjuvant PAXG Outperforms mFOLFIRINOX in Resectable and Borderline Resectable PDAC Read More » June 4, 2025
New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy Read More » February 20, 2025
High-dose IV vitamin C plus chemotherapy doubles survival in advanced pancreatic cancer Read More » November 25, 2024
